CXCR4 inhibitors are compounds designed to block the interaction between CXCR4 and CXCL12. By doing so, they can potentially disrupt the processes that allow cancer cells to grow and spread. Several types of CXCR4 inhibitors are being researched, including small molecules, peptides, and monoclonal antibodies.
